[HTML][HTML] Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance

H Easwaran, HC Tsai, SB Baylin - Molecular cell, 2014 - cell.com
The existence of subpopulations of cells in cancers with increased tumor-initiating capacities
and self-renewal potential, often termed" cancer stem cells," is a much discussed and key …

[HTML][HTML] Folate and DNA methylation: a review of molecular mechanisms and the evidence for folate's role

KS Crider, TP Yang, RJ Berry, LB Bailey - Advances in nutrition, 2012 - Elsevier
ABSTRACT DNA methylation is an epigenetic modification critical to normal genome
regulation and development. The vitamin folate is a key source of the one carbon group …

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

S Turcan, D Rohle, A Goenka, LA Walsh, F Fang… - Nature, 2012 - nature.com
Both genome-wide genetic and epigenetic alterations are fundamentally important for the
development of cancers, but the interdependence of these aberrations is poorly understood …

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

SC Mack, H Witt, RM Piro, L Gu, S Zuyderduyn… - Nature, 2014 - nature.com
Ependymomas are common childhood brain tumours that occur throughout the nervous
system, but are most common in the paediatric hindbrain. Current standard therapy …

[HTML][HTML] Epigenomic analysis of multilineage differentiation of human embryonic stem cells

W Xie, MD Schultz, R Lister, Z Hou, N Rajagopal… - Cell, 2013 - cell.com
Epigenetic mechanisms have been proposed to play crucial roles in mammalian
development, but their precise functions are only partially understood. To investigate …

DNA methylation profiling in the clinic: applications and challenges

H Heyn, M Esteller - Nature Reviews Genetics, 2012 - nature.com
Abstract Knowledge of epigenetic alterations in disease is rapidly increasing owing to the
development of genome-wide techniques for their identification. The ever-growing number …

DNMT1: A key drug target in triple-negative breast cancer

KK Wong - Seminars in cancer biology, 2021 - Elsevier
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer.
Altered epigenetics regulation including DNA hypermethylation by DNA methyltransferase 1 …

Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers

S Rousseaux, A Debernardi, B Jacquiau… - Science translational …, 2013 - science.org
Activation of normally silent tissue-specific genes and the resulting cell “identity crisis” are
the unexplored consequences of malignant epigenetic reprogramming. We designed a …

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

P Wang, Q Dong, C Zhang, PF Kuan, Y Liu, WR Jeck… - Oncogene, 2013 - nature.com
Mutations in the genes encoding isocitrate dehydrogenase, IDH1 and IDH2, have been
reported in gliomas, myeloid leukemias, chondrosarcomas and thyroid cancer. We …

Strategies for the discovery and development of therapies for metastatic breast cancer

BL Eckhardt, PA Francis, BS Parker… - Nature reviews Drug …, 2012 - nature.com
Nearly all deaths caused by solid cancers occur as a result of metastasis—the formation of
secondary tumours in distant organs such as the lungs, liver, brain and bone. A major …